CDKL3 and cholangiocarcinoma: By reducing the expression of the target gene CDKL3 and arresting the cell cycle in the G1 phase, CC inhibits proliferation and promotes apoptosis in cholangiocarcinoma HCCC-9810 and RBE cells (8).